Carter Bankshares (CARE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Apr, 2026Executive summary
The 2026 Annual Meeting will be held on May 27, 2026, to elect 11 directors, approve executive compensation in an advisory vote, and ratify Crowe LLP as independent auditors for 2026.
Shareholders of record as of March 25, 2026, are entitled to vote; 22,159,980 shares are outstanding.
Proxy materials are available electronically, and voting can be done online, by phone, mail, or in person.
Voting matters and shareholder proposals
Shareholders will vote on electing 11 directors, an advisory say-on-pay for executive compensation, and ratification of Crowe LLP as auditors.
Shareholder proposals for the 2027 meeting must be submitted between January 27 and February 26, 2027.
No other business is currently anticipated at the meeting.
Board of directors and corporate governance
The board consists of 11 nominees, with a mix of business, legal, financial, and risk management expertise.
Majority of directors are independent; board leadership is separated between Chairman and CEO.
Board committees include Audit, Nominating & Compensation, Credit Risk, Investment/Interest Rate Risk, and Enterprise Risk Management.
Board diversity: 27% female, average independent director age is 63, average tenure is 6 years.
Latest events from Carter Bankshares
- Earnings surged on a one-time loan sale, sharply improving credit quality and capital ratios.CARE
Q1 202623 Apr 2026 - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing15 Apr 2026 - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025